COMMUNIQUÉS West-GlobeNewswire

AB Science announces the lifting of the ANSM clinical hold
28/05/2019
Paris, May 28 2019, 6pm AB Science announces the lifting of the ANSM clinical hold AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and [...]
AB Science annonce la levée de la décision de suspension des études cliniques par l’ANSM
28/05/2019
Paris, 28 mai 2019, 18h Levée de la décision de suspension des études cliniques par l’ANSM AB Science SA (NYSE Euronext – FR0010557264 – AB), société biopharmaceutique spécialisée dans la recherche et le développement d [...]
Saniona announces rights issue of SEK 78 million underwritten up to 85 percent
28/05/2019
PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION [...]
Zynerba Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
DEVON, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Medtronic EVP & CVG President Mike Coyle to Speak at Jefferies 2019 Global Healthcare Conference
28/05/2019
DUBLIN - May 28, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019, in New York [...]
PCI Biotech: Disclosure of voting rights for Chairman of the Board
28/05/2019
Oslo, 28 May 2019. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual [...]
Vystar Acquires Fluid Energy Conversion Technology Assets, Expands Reach Into New Vertical Markets
28/05/2019
Vystar plans to apply Fluid Energy Conversion (FEC) technology to increase pathogen killing efficiency, reduce size and cost of Vystar’s RxAir air purifiers. FEC technology expected to be used to negate viruses and [...]
INmune Bio to Present at the 9th Annual LD Micro Invitational on June 5th
28/05/2019
LA JOLLA, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced [...]
MiniMed(TM) 670G System Real-World Data on 8 Million Patient Days Shows 71 Percent Time in Range Across All Age Groups
28/05/2019
DUBLIN - May 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more than 180,000 people [...]
Imprivata Extends Healthcare’s Most Seamless EPCS Offering to Support Google Chrome
28/05/2019
Imprivata will showcase Imprivata Confirm ID for EPCS at the 2019 MUSE Inspire Conference LEXINGTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that [...]
Alphatec to Participate in the Jefferies 2019 Global Healthcare Conference and the Raymond James Life Sciences and MedTech Conference
28/05/2019
CARLSBAD, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine [...]
CrossBow with ADAPTOR Honored as Finalist in the 2019 Medical Design Excellence Awards
28/05/2019
Suture Ease, Inc., brings innovative technologies to laparoscopic surgery SAN JOSE, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Suture Ease, Inc. today announced that the CrossBow with ADAPTOR has been selected as a [...]
Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise
28/05/2019
NORCROSS, Ga., May 28, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced its Rights Offering has closed. The Rights [...]
Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo
28/05/2019
NESS ZIONA, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
28/05/2019
- Data demonstrated strong correlation between LymPro and amyloid PET - Todos to present at Alzheimer’s Solutions Conference on June 3, 2019 in Philadelphia - Todos to present at LD Micro on June 4 th , 2019 REHOVOT, [...]
Yield10 Bioscience, Inc. to Present at the Ladenburg Thalmann Technology Expo 2019 on May 30, 2019
28/05/2019
WOBURN, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Corvus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
BURLINGAME, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Wildflower Featured in NetworkNewsWire Publication Highlighting Heightened Media Coverage of CBD Products
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial [...]
MyoKardia Presents Results from Phase 1a Clinical Trial of MYK-491 at the European Society of Cardiology Heart Failure Congress in Athens, Greece
28/05/2019
First-in-Human Data for MYK-491 in Healthy Volunteers Demonstrated Well-Tolerated Increases in Cardiac Contractility Topline Results from Phase 2a Clinical Trial of MYK-491 in Patients with Stable Heart Failure with [...]

Pages